|
Market Closed -
Nasdaq
16:00:00 2026-09-03 EDT
|
5-day change | 1st Jan Change | ||
| 12.68 USD | -0.63% |
|
-3.28% | +41.05% |
| 08-06 | Intellia Therapeutics, Inc., Q2 2026 Earnings Call, Aug 06, 2026 | |
| 08-06 | Wedbush Adjusts Intellia Therapeutics Price Target to $12 From $17, Maintains Neutral Rating | MT |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| NTLA | Delayed | |
CBOE
| NTLA | Real-time | |
|
London S.E.
| 0JBU | Delayed | |
|
Tradegate
| 38I | Real-time | |
|
Berne S.E.
| 38I | End-of-day quote | |
|
Boerse Muenchen
| 38I | Real-time | |
|
Xetra
| 38I | Delayed | |
|
Deutsche Boerse AG
| 38I | Delayed | |
|
Börse Stuttgart
| 38I | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bearish | Neutral |
| Resistance | 13.51 | 13.87 | 25.6 |
| Spread/Res. | -6.14% | -8.58% | -50.47% |
| Spread/Supp. | +7.19% | +18.84% | +54.45% |
| Support | 11.83 | 10.67 | 8.21 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- NTLA Stock
- Charts Intellia Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
